Young cryptogenic ischemic stroke: A descriptive analysis of clinical and laboratory characteristics, outcomes and stroke recurrence

J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105046. doi: 10.1016/j.jstrokecerebrovasdis.2020.105046. Epub 2020 Jun 23.

Abstract

Background and purpose: Ischemic strokes (IS) occur also in young adults and despite an extensive work-up the cause of IS remains very often cryptogenic. Thus, effectiveness of secondary prevention may be unclear. We aimed to analyze a relationship among vascular risk factors (VRF), clinical and laboratory parameters, outcomes and recurrent IS (RIS) in young cryptogenic IS (CIS) patients.

Subjects and methods: The study set consisted of young acute IS patients < 50 years enrolled in the prospective HISTORY (Heart and Ischemic STrOke Relationship studY) study registered on ClinicalTrials.gov (NCT01541163). All analyzed patients underwent transesophageal echocardiography, 24-h and 3-week ECG-Holter to assess cause of IS according to the ASCOD classification. Recurrent IS (RIS) was recorded during a follow-up (FUP).

Results: Out of 294 young enrolled patients, 208 (70.7%, 113 males, mean age 41.6 ± 7.2 years) were identified as cryptogenic. Hyperlipidemia (43.3%), smoking (40.6%) and arterial hypertension (37.0%) were the most frequent VRF. RIS occurred in 7 (3.4%) patients during a mean time of FUP 19 ± 23 months. One-year risk of RIS was 3.4% (95%CI: 1.4-6.8%). Patients with RIS were older (47.4 vs. 41.1 years, p = 0.007) and more often obese (71.4 vs. 19.7%, p = 0.006), and did not differ in any of other analyzed parameters and VRF. Multivariate logistic regression analysis showed obesity (OR: 9.527; 95%CI: 1.777-51.1) and the previous use of antiplatelets (OR: 15.68; 95%CI: 2.430-101.2) as predictors of recurrent IS.

Conclusion: Despite a higher presence of VRF in young CIS patients, the risk of RIS was very low. Obesity and previous use of antiplatelet therapy were found the only predictors of RIS.

Keywords: Cryptogenic; Recurrent ischemic stroke; Vascular risk factors; Young ischemic stroke.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Age of Onset
  • Brain Ischemia / diagnosis*
  • Brain Ischemia / epidemiology
  • Brain Ischemia / physiopathology
  • Brain Ischemia / therapy
  • Echocardiography, Transesophageal*
  • Electrocardiography, Ambulatory*
  • Humans
  • Male
  • Middle Aged
  • Obesity / epidemiology
  • Platelet Aggregation Inhibitors / therapeutic use
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Stroke / diagnosis*
  • Stroke / epidemiology
  • Stroke / physiopathology
  • Stroke / therapy
  • Time Factors

Substances

  • Platelet Aggregation Inhibitors

Associated data

  • ClinicalTrials.gov/NCT01541163